2
Total investments
0
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Experience ยท 5 entries
All (5)
Investments (2)
Founder (3)
Board (1)
2021
Early investor
Jan 2021
Tarform Motorcycles is an automotive startup with a mission to set a new standard for two wheeled transportation. We are launching a new breed of electric motorcycles by integrating cutting edge technology, green mobility and smart connectivity.
CEO, Co-founder
Jan 2021
IntuiCell is on a mission to implement biological intelligence. We build a fundamentally new platform for intelligent machines that is capable of learning and adapting to changes in the environment, just like any human or animal.
Underpinned by novel findings on how the brain functions - our goal is to enable general-purpose AI and unlock a technological revolution.
2019
Y
Yehego
Founder & Chairman
Aug 2019
2016
N
Nextmune
Board Member
May 2016
2011
Chief Executive Officer, Co-founder (exit 2020)
Dec 2011
The world is seeing a rising allergy epidemic. This increasing prevalence in the Western world is closely linked to our hygienic lifestyle. A reduced exposure to bacteria during infancy delays activation of immunological defense mechanisms that protect from allergies.
Dogs have followed in our footsteps over thousands of years, and many of the factors associated with increased allergy in humans is highly significant also for dogs. Allergy is considered one of the major diseases in dogs. It is estimated that over ten percent of all dogs suffer from allergies. In certain breeds, such as Bull Terriers, Boxers, and German Shepherds, the risk is significantly higher. Most common allergic disorders are atopic dermatitis (eczema) and food allergies, requiring life-long symptomatic treatment entailing high costs for the dog owner.
Premune is developing a preventive technology that has the potential to change the view on canine allergy treatment. The discovery is based on fifteen years of detailed cohort studies where Premune has identified that infants exposed to a certain bacterial protein in the gut during the first weeks of life are protected from future allergy development. In animal trials the proteins ability to activate immunological tolerance has been confirmed.
This product will be given as oral drops to the puppy during the first few weeks of life, in order to activate the immune systems natural defense against allergies.
